Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Proteomics & Protein Research » SurroMed Wins Phase I SBIR to Develop Chemical Affinity Agents

SurroMed Wins Phase I SBIR to Develop Chemical Affinity Agents

Aug 26, 2002
Premium

SurroMed said last week that the National Cancer Institute had awarded the company a phase I Small Business Innovation Research (SBIR) grant to support research into developing new capture chemistries for use in proteomic profiling of biological samples. The grant of $150,000 is meant to cover research costs for about a year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

A Start

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

Just Go 'Round the CDC

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

Student Visa Directive Rescinded

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

Cell Studies on Blood Features of Severe COVID-19 Cases, Infection-Related Phosphorylation Shifts, More

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.

What's Popular?

In Proteomics & Protein Research

  1. Newly Proposed B Cell Atlas Identifies 12 Unique Subsets

  2. Waters Reports Preliminary Q2 Revenue Drop of 13 to 14 Percent, Names New CEO

  3. Integrated Proteomic Papers Define Lung Cancer Features Across Populations, Smoking Histories

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.